Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
ARWR
Showing 7 of 24 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in Arrowhead Pharmaceuticals, Inc.
No. Farallon Capital Management exited its ARWR (Arrowhead Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 15,800 shares worth $990,660. Farallon Capital Management already held ARWR in its Q4 2018 13F, the earliest on record, and held it in 21 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$11.8M
Total Shares Change
-628,800
Quarter-by-Quarter History